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Introduction 24
Understanding if and how species can adapt to rapidly changing environmental conditions is a 25 primary goal of modern conservation biology (Bernatchez, 2016; Stockwell, Hendry, & 26 Kinnison, 2003) . One of the key challenges in meeting this goal is uncovering the adaptive 27 genetic variation required for a response to selection and deciphering whether this adaptive 28 genetic variation will be sufficient to respond to anthropogenically-induced agents of selection. Christie, 2018). However, such methods often lack sufficient power to detect rapid responses to 33 selection, especially when examining polygenic traits shaped by large numbers of loci of small 34 effect (Pritchard, Pickrell, & Coop, 2010; Wellenreuther & Hansson, 2016) . Furthermore, 35 genomic approaches can only provide insights after selection has already occurred; thus their 36 utility for predicting responses to selection requires appropriate study systems or long-term 37 experimental breeding designs. One alternative to these approaches is experimental 38 transcriptomics. By carefully designing treatments, rearing F1 offspring in a common 39 environment, and deeply sequencing mRNA, it is possible to uncover an adaptive, genetic and formal survival analyses allows for the disentanglement of treatment effects, required for 43 understanding how individuals plastically respond to environmental stressors, and among-family 44 variation in survival and gene expression. Here, we apply these techniques to a threatened fish 45 population, whose successful reintroduction will require an adaptive response to an emerging 46 conservation issue, thiamine deficiency. 47
Evidence is mounting that populations of diverse taxa are becoming increasingly 48 deficient in thiamine (vitamin B1) (Balk et al., 2009 (Balk et al., , 2016 . For example, high rates of mortality 49 or reduced reproductive success associated with thiamine deficiency have been observed in 50 invertebrates (Balk et al., 2016) , fishes (Futia et al., 2017) , reptiles (Honeyfield et al., 2008; Ross 51 et al., 2009) , and birds (Balk et al., 2009 ). Furthermore, many cases of thiamine deficiency 52 remain undetected. From a conservation standpoint, it is particularly concerning that thiamine 53 deficiency remains largely undetected despite potentially being a large driver of population 54
declines. 55
Thiamine is an essential vitamin that is synthesized by prokaryotes, plants, and fungi; 56 animals are incapable of producing thiamine and primarily acquire the vitamin through their 57 diets (Bettendorff, 2013) . The physiological manifestations of thiamine deficiency are directly 58 related to thiamine's roles in bioenergetic, neurological, and cardiovascular pathways. Thiamine 59 serves as a cofactor for enzymes in metabolism and energy production pathways (i.e., pentose 60 phosphate pathway and tricarboxylic acid cycle) and thiamine deficiency leads to extreme 61 lethargy (Brown et al., 2005; Fitzsimons, Brown, Honeyfield, & Hnath, 1999) . Thiamine is also 62 required for production of neurotransmitters, antioxidants, and myelin (Bettendorff, 2013) , 63 consistent with the neurological and behavioral signs of thiamine deficiency, including brain 64 lesions (Butterworth, 2009 Sechi & Serra, 2007) . Thiamine deficiency can also impair 67 cardiovascular function, leading to low blood pressure, irregular heart rate, pulmonary edema, 68 and circulatory collapse (Essa et al., 2011; Sechi & Serra, 2007) . Because thiamine plays a 69 central role in growth, development, and proper neurological function (Bettendorff, 2013) , 70 thiamine deficiency can impair an individual's capacity to forage, avoid predation, and reproduce 71 (Carvalho et al., 2009; Fisher, Spitzbergen, et al., 1995; Fitzsimons et al., 2009 ), all of which can 72 contribute to large reductions in population size (Ketola, Bowser, Wooster, Wedge, & Hurst, 73 2000; Mörner et al., 2017) . 74
The underlying causes of thiamine deficiency vary among taxa and environments. In 75 fishes, the emergence of thiamine deficiency is largely attributed to diet. For example, thiamine 76 deficiency has often been observed in salmonids with diets containing alewife (Alosa 77 pseudoharengus) and rainbow smelt (Osmerus mordax), both of which contain high levels of 78 thiaminase, a thiamine-degrading enzyme (reviewed in Harder et al., 2018) . In the Baltic Sea, the 79 occurrence of thiamine deficiency in Atlantic salmon (Salmo salar) also coincides with the 80 consumption of fishes with low thiamine:fat content ratios, including Atlantic herring (Clupea 81 harengus) and sprat (Sprattus sprattus) (Hansson et al., 2001; Keinänen et al., 2012) . However, 82 these fishes also contain thiaminase, making it difficult to establish low thiamine:fat content 83 ratios as direct, causative agents of thiamine deficiency. For adult salmon returning to spawn, the 84 most obvious signs of thiamine deficiency are uncoordinated, "wiggling" swimming patterns and 85 an inability to remain upright in the water column (Fisher, Spitsbergen, Iamonte, Little, & 86 Delonay, 1995; Fitzsimons et al., 2005) . If thiamine deficient individuals are able to spawn, these 87 behaviors are inevitably mirrored in their offspring. Individuals hatching from thiamine deficient 88 eggs do not survive for more than a few weeks and exhibit physical signs of deficiency, such as 89 hemorrhaging and large yolk sacs with opacities and edema, prior to death ( Fig. 1A) (Fisher, 90 Spitsbergen, et al., 1995) . The inability of thiamine deficient salmon to successfully reproduce is 91 an emerging conservation and management issue (reviewed in Harder et al., 2018) , and impedes 92 reintroduction efforts throughout their native range. 93
One such reintroduction effort occurs in Lake Champlain (Canada and USA), where 94
Atlantic salmon were extirpated from the lake in the early 1800s (Marsden & Langdon, 2012; SI 95 Introduction). Diversifying the forage base or controlling the alewife population in Lake 96
Champlain could alleviate thiamine deficiency in Atlantic salmon, but efforts to eradicate 97 invasive species after population establishment are often prohibitively expensive and the 98 possibility of reinvasion cannot be eliminated (Myers, Simberloff, Kuris, & Carey, 2000) . 99
Alternatively, recent research suggests that Atlantic salmon populations with diets high in 100
thiaminase may have genetically adapted to low thiamine availability (Houde, Saez, Wilson, 101 Bureau, & Neff, 2015) . This rapid genetic adaptation could be the result of selection on genes 102 associated with thiamine-dependent pathways. For example, conformational changes in enzymes 103 requiring thiamine as a cofactor could increase the binding affinity for thiamine or, alternatively, 104 variation in regulatory sequences could modify the expression of genes involved in thiamine 105 uptake and intracellular transport. However, the application of supplemental thiamine to all 106 fertilized eggs reared in the Lake Champlain hatchery precludes selection related to thiamine 107 deficiency at early life stages, and it is currently unknown whether genetic variation in this 108 population could support a response to such selection. By coupling thiamine treatments, RNA-109 seq, and survival analyses on F1 offspring from 9 families raised in a common environment, we 110 identified an among-family adaptive response in a thiamine-deficient population of Atlantic 111 salmon and identified pathways and functions impacted by thiamine deficiency. Categorizing 112 relationships between gene expression and survivorship patterns revealed two distinct groups of 113 differentially expressed genes that (1) underlie putatively adaptive responses to thiamine 114 deficiency among families and (2) reflect the treatment effect of thiamine use regardless of 115 genetic differences. Our results are consistent with a heritable, among-family basis for tolerance 116 to low thiamine availability. 117
Methods 118

Study system and experimental crosses 119
We collected gametes from 35 pairs of adult male and female Atlantic salmon returning to the Ed 120 systematically combined milt and eggs to generate 35 families (see SI Methods for crossing 129 details). We divided fertilized eggs from each family into two groups, placing one group into a 130 monitor and remove dead individuals from all trays each week for the remainder of the 138 experiments. We concluded the experiments after surviving fry had absorbed their yolk sacs 139 (~130 days post fertilization) and just prior to initiation of exogenous feeding. 140
Sampling for RNA-seq 141
At 95 days post fertilization, we sampled a total of thirty-six individuals for gene expression 142 analyses from 9 of the 18 families spawned in 2017. Due to hatchery broodstock quotas for 143 treated individuals, we were limited to sampling these 9 families. To control for variation in 144 development, we only sampled from families that were spawned on the same day. We froze 145 individuals from each family and treatment group in dry cryogenic shipping dewars charged with 146 liquid nitrogen and shipped them to Purdue University for storage at -80 °C. We subsequently 147 placed two frozen individuals from each family and treatment group (n = 9 families * 2 148 treatments (+/-supplemental thiamine) * 2 individuals = 36) into 10 volumes of RNAlater-ICE 149 (Invitrogen) pre-chilled to -80 °C and allowed the samples to reach -20 °C overnight. We then 150 homogenized samples using a TissueRuptor II (Qiagen) and extracted total RNA from each 151 homogenate using an RNeasy kit (Qiagen). 152
Survival analyses 153
We generated a dose-response curve for egg thiamine concentration and proportion of untreated 154 individuals in each family surviving at the end of the experiments with the drc package (Ritz, 155 Baty, Streibig, & Gerhard, 2015) in R version 3.5.3 (R Core Team, 2019). We selected the 156 appropriate model by using the mselect function to calculate AIC values, with the two-parameter 157 log-logistic function having the lowest AIC value. We next calculated effective concentrations of egg thiamine required for 25% and 50% survival (EC25 and EC50, respectively) from the 159 resulting logistic curve. 160
For the 9 families used in RNA-seq, we conducted survival analyses to determine 161 whether treatment affected survival within a family over time and to determine the relative risks 162 of death associated with belonging to each family according to survivorship of untreated 163 individuals. We constructed Kaplan-Meier survival distributions for each family and treatment 164 combination and used a log-rank test to determine whether treatment status significantly affected 165 survival within each family (Kleinbaum & Klein, 2012) . We then compared survival 166 distributions for untreated individuals from each family against the survival distribution for 167 untreated individuals from family A (the family with the highest survival rate of all families). We 168 used Cox proportional hazards regressions to calculate hazard ratio values for all families (Cox, 169 1972) using the survival package (Therneau, 2015) in R. We censored individuals removed for 170 RNA-seq in the analysis. For each family, the calculated hazard ratio represents the probability 171 of mortality associated with belonging to that family, compared to family A. We also conducted 172 a linear regression to test for a relationship between hazard ratio value and egg thiamine 173 concentration. To meet assumptions of normality, we log-transformed hazard ratio values prior 174 to all regression analyses. 175
When spawning families for this study, reciprocal crosses were not feasible due to limited 176 egg and milt availability, therefore, we could not formally test for maternal effects (sensu 177
Christie et al., 2016). However, female size is often correlated with offspring size, and larger 178 offspring frequently exhibit higher fitness than smaller offspring in a common environment 179 (reviewed in Marshall, Heppell, Munch, & Warner, 2010). We therefore performed linear 180 regressions to test for relationships between maternal physical characteristics (i.e., standard length and weight) and proportion of untreated offspring surviving at the end of the experiment. 182
We also plotted maternal muscle and egg thiamine concentration against proportion of untreated 183 offspring surviving for the 9 families sampled for RNA-seq. A strong association between 184 maternal characteristics and untreated offspring survival might indicate that maternal condition 185 plays a larger role in determining thiamine deficiency outcomes than among-family genetic 186 variation. 187
RNA-seq and sequence processing 188
We assessed total RNA concentration and quality on an Agilent BioAnalyzer at the Purdue 189
Genomics Core Facility, with sample RIN scores ranging from 9.3-10.0. One library was 190 prepared for each individual using the TruSeq Stranded mRNA protocol (Illumina) and cDNA 191 was sequenced on an Illumina NovaSeq 6000 to generate an average of 87 million 150 bp paired-192 end reads per library (Table S1 ). We removed adapter sequences and clipped poor quality bases 193 chimeric fragments (-C option) and requiring that both reads in a pair be successfully mapped (-202 B option). By default, featureCounts does not count reads with multiple alignments (i.e., a single 203 read aligned to multiple locations in the reference) or read pairs that overlap multiple features, 204 and we retained these settings in our analyses. 205
Differential expression analyses: treatment effects 206
We first made comparisons between treated and untreated individuals using both an a priori list 207 of reference genes and a standard discovery-based gene identification pipeline. We generated a 208 list of a priori genes predicted to be differentially expressed between treated and untreated 209 samples using 4 criteria: (1) genes associated with thiamine-related biological process gene 210 ontology (GO) terms (any line containing "thiamine" in Ssal_ICSASG_v2_GOAccession.txt salar thiamine metabolism pathway in the NCBI BioSystems Database (BSID: 1429556). 215
We conducted differential gene expression analyses separately in DESeq2 (Love, Huber, 216 & Anders, 2014) for: 1. the a priori list of predicted differentially expressed genes (DEGs) and 217 2. the list of all assembled transcripts. We identified DEGs associated with thiamine treatment 218 status while controlling for the effects of family, and considered genes with an FDR-adjusted p-219 value (padj) < 0.05 to be differentially expressed. We used the prcomp command in R to conduct 220 a principal component analysis for DEGs identified from the list of all assembled transcripts. 221
Using the count matrix for all samples, we identified modules of co-expressed genes by 222 calculating pair-wise Pearson correlations between each pair of genes using the WGCNA 223 package (Langfelder & Horvath, 2008) . We set the minimum modules size to 30 genes and 224 merged correlated modules (r 2 > 0.9). Each module comprised genes that showed similar 225 expression patterns across samples within a treatment. Following the approach outlined in 226
Langfelder and Horvath (2008) we performed the following steps. First, we summarized module 227 expression using a principal components analysis (PCA) and calculated eigengenes as the first 228 principal component (PC1) for each module. Second, we used the Pearson correlation to search 229 for associations between module eigengenes and treatment status, and calculated p-values for 230 correlations using a Student's asymptotic test. Finally, we applied a Bonferroni correction to 231 account for multiple testing. 232
For each module significantly associated with treatment status, we performed a gene 233 ontology (GO) enrichment analysis to identify which Biological Process GO terms associated 234 with the DEGs were overrepresented compared to the genome-wide complement of S. salar GO 235 terms (p < 0.001). We used the TopGo package in R (Alexa & Rahnenfuhrer, 2016) , which is 236 less biased towards the most general GO terms because it employs a hierarchical methodology, 237 and chose the 'weight01' algorithm because this method efficiently identifies enriched terms at 238 all levels of the GO hierarchy while limiting the proportion of false positives (Alexa, 239 Rahnenfuhrer, & Lengauer, 2006) . After identifying overrepresented GO terms in each module, 240
we created a list of terms unique to each module (all overrepresented terms shared among all 3 241 modules are provided in Table S2 ). For each module, we created a list of the top 20 genes ranked 242 by gene significance (a value calculated in WGCNA that indicates the biological significance of 243 a module gene with respect to the explanatory variable of interest). We used unique GO terms 244 associated with the top 20 genes to construct a network of GO terms for each module, and the 245 metacoder package (Foster, Sharpton, & Grünwald, 2017) to visualize networks in R. We pruned 246 internal nodes from each network for ease of visualization.
Identifying putatively adaptive genes 248
To identify putatively adaptive genes that could respond to selection imposed by thiamine 249 deficiency, we generated a transcript count matrix for untreated individuals only. We conducted 250 differential gene expression analysis on this group in DESeq2 in R with family hazard ratio value 251 as the explanatory variable. We considered genes with padj < 0.05 and with a fold-change > 1 252 (log2 fold-change > 0.5 between the families with the lowest and highest hazard ratio values) to 253 be putatively adaptive. 254
We further categorized the adaptively expressed genes by whether increasing hazard ratio 255 (i.e., increasing probability of mortality) was associated with either an increase or a decrease in 256 gene expression, when analyzed across families. We further filtered genes belonging to each 257 category by applying a linear regression approach to each gene, with log(hazard ratio) as the 258 explanatory variable and overall gene expression (fragments per million mapped fragments, 259 FPM) as the response variable. To account for the fact that we sequenced two siblings from each 260 family, we conducted each regression using 1 randomly selected individual from each family, 261 and repeated this process 1,000 times per gene. We calculated coefficient means for each gene 262 and variances in the means as 95% confidence intervals. We discarded genes from further 263 analyses if the slope of the regression did not differ from 0 or if the adjusted r 2 of the regression 264 was < 0.3. For each group of putatively adaptive genes, we performed a gene ontology (GO) 265 enrichment analysis using the same approach described above. We ranked GO terms by p-value 266 for each category and retained the top 50 terms from each group (p < 0.001 for all retained 267 terms). 268
Categorizing treatment effects: additive vs. family x treatment interactions 269
To categorize treatment effects, we first limited our analyses to genes previously identified as 270 differentially expressed with respect to thiamine treatment (see "Differential expression analyses: 271 treatment effects" section above). Additive effects occur when the response to the thiamine 272 treatment was equal across families. When the slopes of both treatment and controls do not differ 273 from zero across families, this pattern represents a purely environmental response to thiamine 274 treatment. By contrast, one family may respond to thiamine treatment differently than another, 275 and this pattern can result in a family x treatment interaction. Using this approach, we can 276 disentangle among-family (i.e., putatively adaptive) variation in gene expression from both an 277 additive (purely environmental) response to treatment and a family x treatment interaction. We 278 calculated regressions separately for each treatment group with log(hazard ratio) as the 279 explanatory variable and fragments per million mapped fragments (FPM) as the response 280 variable. We again conducted each regression using 1 randomly selected individual from each 281 family and treatment combination and repeated this process 1,000 times per gene. We identified 282 significant differences between the treatment and control groups by comparing the bootstrapped 283 coefficient estimates for slope and intercept. To approximate a significance cut off of α = 0.05, 284
we identified genes where the mean coefficient estimate +/-1 standard error (approximated by 285 83% quantiles; Payton, Greenstone, & Schenker, 2003) between the treatment and control groups 286 did not overlap. In addition, slopes were considered to not differ from zero if their 95% 287 confidence intervals included zero. We also categorized genes according to whether or not the 288 slopes or intercepts of the treated and untreated regression lines differed from one another.
Results 290
Thiamine concentration and survival analyses 291
In 2016 and 2017, the proportion of untreated individuals surviving within each family varied 292 widely and ranged from 0 to 0.99 (mean = 0.25, SD = 0.34) (Fig. 1B) . Total thiamine 293 concentrations in unfertilized eggs were also variable and ranged from 0.98 to 12.71 nmol total 294 thiamine/g unfertilized egg tissue (mean = 3.09 nmol/g, SD = 2.23 nmol/g). Fitting a dose-295 response curve to the relationship between egg thiamine concentration (nmol/g) and proportion 296 of untreated individuals surviving at the end of each experiment resulted in an EC25 of 2.89 297 nmol/g and an EC50 of 5.46 nmol/g (i.e., 5.46 nmol/g of thiamine is required for 50% survival) 298 ( Fig. 1C) . 299
Within each of the 9 families sampled for gene expression analyses, Kaplan-Meier 300 survival distributions for treated and untreated individuals were significantly different (log-rank 301 test; family A: p < 0.01, families B-I: p < 0.0001), indicating that thiamine treatment 302 significantly and positively impacted survival over time for all families (Fig. S1 ). Hazard ratios 303 ranged from 1 (for reference family A) to 80.12 (family I). Hazard ratio values > 1 indicate that a 304 higher risk of death is associated with belonging to a particular family (i.e., the risk of death 305 associated with belonging to family I is 80.12 times greater than the risk of death associated with 306 belonging to family A). 307
Differential expression analyses: treatment effects 308
Across all 36 individuals sequenced, the average rate of single concordant alignment for read 309 pairs per sample was 80.9% and 62.2% of read pairs were successfully assigned to annotated 310 features with featureCounts (Table S1 ). The final list of a priori genes included 106 unique 311 genes. Of these genes, 17 were differentially expressed between treated and untreated individuals 312 after controlling for false discovery (padj < 0.05; Table 1 ). Three of these genes-which encode 313 adenylate kinase and reduced folate carrier-are involved in regulating intracellular 314 concentrations of TDP (Fig. S2 ). Most of the remaining a priori DEGs comprise TDP-dependent 315 enzymes or kinases that control TDP-dependent enzyme activity (Table 1) . Differential 316 expression analysis conducted using the full list of assembled transcripts resulted in the 317 identification of 3,616 DEGs after controlling for false discovery (padj < 0.05; Table S3 ). A 318 principal component analysis conducted with these DEGs showed treated samples clustering 319 closely together, with PC1 differentiating treated and untreated individuals within each family 320 and describing 59% of the variation (Fig. 2) . 321
Gene co-expression network and gene ontology analyses: treatment effect genes 322
After Bonferroni correction, 3 WGCNA modules of co-expressed genes were significantly 323 correlated with treatment status (corrected p < 0.05). Module A contained 667 genes and these 324 genes were associated with 647 significantly overrepresented GO terms; 46 GO terms were 325 unique to Module A and associated with the top genes in the module when genes were ranked by 326 gene significance (terminal nodes in Fig. 3A , Table S4 ). Many GO terms associated with genes 327
in Module A were related to neurological function and development, including regulation of 328 long-term neuronal synaptic plasticity, neurotransmitter secretion, and neuromuscular junction 329 development (Fig. 3A) . Differential expression of genes involved in neurological function may 330 underlie the abnormal locomotion patterns observed in thiamine deficient fry. Module B 331 contained 355 genes associated with 261 significantly overrepresented GO terms; 17 GO terms 332 were unique to Module B and associated with the top genes in the module. Of these 17 GO 333 terms, 8 were associated with metabolism, including positive regulation of insulin secretion, 334 glutamine metabolic process, and tricarboxylic acid metabolic process (Fig. 3B) . Differential expression of genes related to these terms is likely related to diminished metabolic rates in 336 untreated individuals. Module C contained 470 genes associated with 768 significantly 337 overrepresented GO terms; 51 GO terms were unique to Module C and associated with the top 338 genes in the module. Many of these GO terms were related to cardiovascular function and 339 development, such as oxygen transport, endocardium formation, and blood vessel maturation 340 ( Fig. 3C) . 341
Additionally, all three modules contained terms related to vision, including visual 342 learning, retinal metabolic process, adaptation of rhodopsin mediated signaling, and post-343 embryonic camera-type eye development. Differential expression of genes related to these terms 344 in untreated individuals is likely associated with decreased visual acuity documented in thiamine 345 deficient fry (Carvalho et al., 2009 ). Each module also contained DEGs identified through 346 differential expression analysis (representing 23.4%, 18.3%, and 24.5% of genes in each module, 347 respectively). The DEGs assigned to module A were downregulated in treated individuals, while 348 the DEGs assigned to modules B and C were upregulated in treated individuals (Fig. S3) . 349
Putatively adaptive genes 350
Maternal effects may influence among-family variation in survival and gene expression. 351
However, we could not identify any maternal characteristics, including maternal thiamine 352 concentrations, that were associated with survival of untreated offspring. Specifically, maternal 353 size and weight were not correlated with untreated offspring survival rate (standard length: F1,32 354 = 0.15, p = 0.70; weight: F1,31 = 0.10, p = 0.75), indicating that differences in survival among 355 families is not simply a function of maternal condition (Fig. 4A,B ). Furthermore, for the 9 356 families sampled for RNA-seq, no relationship appears to exist between maternal muscle or egg 357 thiamine concentrations and proportion of untreated offspring surviving (n = 8 and n = 9, 358 respectively; Fig. 4C,D) . Results of linear regressions also indicated that egg thiamine 359 concentration was not a significant predictor of log(hazard ratio) (F1,7 = 2.18, p = 0.18; Fig. S4 ). 360
Although we cannot entirely rule out the influence of maternal effects, these results suggest that 361 maternal effects are not driving all of the among-family variation in survival. 362
Differential expression analyses conducted using a count matrix for only untreated 363 individuals (n = 18) and with family hazard ratio as the explanatory variable yielded 1, 656 364 DEGs. Of these DEGs, 471 were discarded because the adjusted r 2 of the regressions for these 365 genes were < 0.3, and an additional 210 were discarded because the regression slopes did not 366 significantly differ from 0. The remaining 1,446 putatively adaptive DEGs were divided into 812 367 genes positively associated with increased risk of mortality ( Fig. 5A,C) and 634 genes negatively 368 associated with increased risk of mortality ( Fig 5B,C; Table S5 ). 369
Adaptively expressed DEGs with positive and negative slopes were associated with 870 370 and 741 overrepresented GO terms, respectively (p < 0.001). Of the top 50 terms associated with 371 genes in each slope category, 17 terms were shared between the categories (Table S6 ). Shared 372 terms were related to a variety of processes, including regulation of transcription, response to 373 glucose, aging, and oxidation-reduction process. Terms associated with genes with negative 374 slopes (i.e., genes upregulated in families with high survival) relate to growth and developmental 375 processes, including cellular proliferation, DNA replication, embryo development, neurogenesis, 376 and visual perception (Table S6 ). Genes with positive slopes (i.e., genes upregulated in families 377 with low survival) were associated with terms that seems to indicate stressful physiological 378 conditions, including response to hydrogen peroxide, response to hypoxia, response to toxic 379 substance, and several terms related to toll-like receptor signaling pathways (Table S6) .
Additive and treatment x among-family effect genes 381
The differential expression of 114 genes in response to thiamine treatment was driven entirely by 382 additive effects, meaning that the response to treatment was equal among families ( Fig. 6A ). Of 383 these 114 genes, 84 genes also showed no among-family variation in gene expression, suggesting 384 that the response to thiamine in this group of genes is entirely environmental (i.e., not genetic). 385
For 30 additively expressed genes, we also identified significant among-family variation in 386 expression, suggesting that these genes are both putatively adaptive and additive (i.e., they 387 respond equally across families) ( Fig. 6A,B ). For example, expression level of popeye domain-388 containing protein 2 (popdc2; SI Discussion) decreases with increasing hazard ratio rank for both 389 treatment groups, with equal slopes between treatments (Fig. 6B) . 390
For 597 genes differentially expressed with respect to treatment, the slopes of the 391 regressions for each treatment group differed, indicating a family x treatment effect. The vast 392 majority (460/720) of family-and treatment-effect genes fell into two categories (Fig. 6A) , both 393 of which had a shared y-intercept (see Fig. S5 for all identified categories). Gene expression 394 between treated and untreated individuals was most similar at lower hazard ratio values, with 395 expression levels of treated and untreated individuals diverging with increasing hazard ratio. For 396 example, expression levels of the optineurin and gamma-crystallin M2 genes did not differ 397 between treatments for the family with the highest survival (lowest hazard ratio value) ( Fig.  398 6C,D). These two genes differ in their responses to treatment; thiamine treatment decreases 399 expression of optineurin in low survival families, whereas treatment increases expression of 400 gamma-crystallin M2 in low survival families. Because the slopes of the treatment group 401 regressions differ, treatment does not evenly affect gene expression across families; the families 402 with the lowest survival (highest hazard ratio values) experienced the largest shifts in expression 403 levels in response to treatment. 404
Discussion 405
Among all families and across both years, we found a high degree of variation in survival (Fig.  406   1B) and egg thiamine concentrations, with most females producing eggs that cannot survive 407 without supplemental treatment (Fig. 1C) . The ubiquity of low egg thiamine in these samples is 408 consistent with extremely limited reproductive success documented in Lake Champlain 409 tributaries (Prévost, Hill, Grant, Ardren, & Fraser, in press). Treatment with supplemental 410 thiamine does improve survival outcomes for all families, but does not guarantee survival in 411 families with higher hazard ratios ( Fig. S1D-I) . Egg thiamine concentration could not predict 412 survival (hazard ratio value) for the 9 families included in gene expression analyses (Fig. S4) , 413 and no relationships appear to exist between maternal muscle or egg thiamine concentrations and 414 proportion of untreated offspring surviving (Fig. 4C,D) . Across all families, maternal length and 415 weight also do not predict offspring survival (proportion surviving; Fig. 4A,B ). Because all 416 offspring were raised in a common environment, the absence of this relationship coupled with 417 the high variation in among-family survival indicates that family identity (i.e., genetic 418 background) plays an important role in determining whether an individual will survive thiamine 419 deficiency. Furthermore, in the face of thiamine deficiency, certain families are better able to 420 maintain gene expression profiles that approximate expression profiles under thiamine-rich 421 conditions without the aid of supplemental thiamine (Fig. 6) , consistent with a genetic basis for 422 tolerance to low thiamine availability. 423
Across all families, we found that a large number of genes responded to supplemental 424 thiamine treatment. Of the genes hypothesized to be differentially expressed between treated and 425 untreated individuals a priori, two gene products perform functions that balance relative 426 intracellular concentrations of thiamine and its various derivatives (see SI text for Discussion; 427 Fig. S2 ). From the full list of transcript counts, we identified three modules of co-expressed 428 genes associated with treatment status (Fig. 3) . For each of these modules, clear themes emerged Differential responses to thiamine deficiency among families comprise 1,446 putatively 447 adaptive genes. These genes are putatively adaptive because their expression level is directly associated with among-family variation in survival. For example, 812 genes are significantly 449 upregulated in untreated individuals from high-survival families (Fig. 5A,C) . This result suggests 450 that the increased expression of these genes is associated with higher survival and that these 451 genes, or the various cis or trans acting regulatory elements that influence their expression, could 452 respond to selection in a thiamine-poor environment. Of course, these putatively adaptive genes 453 could also be affected by maternal effects, though survival was not correlated with any maternal 454 or egg traits that we measured (Fig. 4) , heritable epigenetic effects (Le Luyer et al., 2017), or 455 other environmental factors. Thus, we are not suggesting that all of these genes would underlie 456 an adaptive response to selection, but rather that this list represents a suite of candidate genes 457 that would likely respond to selection. The fact that there are so many survival-associated genes 458 implicated in an among-family response also suggests that there is sufficient underlying genetic 459 variation in the population to respond to selection. This result, coupled with our survival data, 460
suggest that this population could adaptively respond to selection in the wild. It is worth noting 461 that there is no natural reproduction in Lake Champlain and that all released salmon are treated 462 with supplemental thiamine; this relaxed natural selection could be limiting the successful 463 reintroduction of salmon into the wild. 464
Of the 3,616 treatment-effect DEGs, 84 displayed evidence of an additive effect of 465 treatment that was not associated with among-family survival (Fig. 6A) . In other words, these 84 466 genes responded to thiamine treatment equally across families and represent a consistent 467 environmental response to the treatment condition. The lack of association between among-468 family variation in survival and the expression of these genes and the fact that these genes 469 changed in expression roughly equally across families suggests that the change in expression due 470 to thiamine is an entirely environmental response. Thus, we would not predict these genes to 471 respond to selection in a thiamine-poor environment. A small subset of putatively adaptive genes 472 (n = 30) exhibited an additive response to treatment across families (i.e., the slopes of the 473 regressions were non-zero but did not differ with respect to treatment) ( Fig. 6A,B ; SI 474 Discussion). By contrast, 597 DEGs were adaptively expressed and provided evidence of a 475 family x treatment interaction. Most of the genes exhibiting both treatment and family effects 476 (460/720 or 64%) followed predictable patterns of expression that can be broadly grouped into 477 two out of six identified categories ( Fig 6D; see Fig. S5 for all family x treatment patterns). For 478 both categories, expression is most similar between treatments in families with high survival and 479 begins to diverge as survival declines. These results illustrate that treatment can have different 480 effects on different families. The fact that the majority (64%) of family x treatment-effect genes 481 occur in the two categories with shared y-intercepts indicates that a successful response to 482 thiamine-poor conditions involves the maintenance of homeostatic conditions. 483
Conclusion 484
Across families, we found no relationship between egg thiamine concentration, maternal traits, 485 and the risk of mortality due to thiamine deficiency, indicating that among-family genetic 486 variation plays an important role in determining thiamine deficiency outcomes. Through gene 487 co-expression network analyses, we determined that many GO terms associated with top DEGs 488 are consistent with observed behavioral and physical signs of thiamine deficiency. Specifically, 489 terms related to neurological function and development, metabolism, cardiovascular function, 490
and visual system development parallel signs of deficiency including uncoordinated swimming 491 patterns, stunted growth, irregular heart rate, and decreased visual acuity. We also described two 492 broad categories of gene expression patterns in response to thiamine deficiency: (1) putatively 493 adaptive genes, which underlie family-level differences in tolerance to low thiamine availability and represent candidate genes likely to respond to selection, and (2) treatment effect genes, 495 which comprise additive and family x treatment effect responses to changes in available 496
thiamine. An additive response coupled with no among-family variation in expression identifies 497 genes that are plastic and respond purely as a function of the treatment condition (i.e., different 498 environments). Such genes would be useful to identify in scenarios where a response to selection 499 was not desirable (e.g., captive breeding programs). Family x treatment effect genes, on the other 500 hand, can be associated with differences in among-family variation in survival, and illustrate that 501 genetic background can differentially affect patterns of gene expression. More importantly, our 502 results identified putatively adaptive genes that would likely respond to selection and that are 503 directly associated with among-family variation in survival. Precisely how much of a response to 504 selection in the wild could occur remains unknown, but uncovering the adaptive genetic variation 505 required for a response to selection represents the first step towards the successful management 506 and conservation species threatened by changing environmental conditions. 507 Table 1 . Genes identified as differentially expressed that were hypothesized a priori to be implicated in thiamine deficiency. Gene symbols correspond to those used in S. salar NCBI assembly GCA_000233375.4 (Lien et al., 2016) . Direction of log2 fold change values indicate direction of regulation in the treated group relative to the untreated group. Genes without chromosome arm information are located on unplaced scaffolds in the S. salar reference assembly.
Gene symbol
Gene description Proportion of untreated fry surviving to the onset of exogenous feeding for 35 families spawned 700 in 2016 and 2017. C) Dose-response curve illustrating the relationship between total egg 701 thiamine concentration (nmol/g) and proportion of untreated fry surviving to yolk sac absorption. 702
Shaded grey areas highlight families with egg [thiamine] < EC25 (dark grey) and with egg 703
[thiamine] >EC25 but <EC50 (light grey), where EC25 and EC50 equal the effective concentrations 704 required for 25% and 50% survival, respectively . 705 for three modules (A, B, and C) of co-expressed genes significantly associated with treatment 717 status. Included GO terms were unique to each module and were associated with at least one of 718 the top 20 genes in that module when genes were ranked by WGCNA gene significance. Branch 719 and node colors indicate the biological process child term to which distal nodes belong, with the 720 central grey node representing the biological process level of the GO hierarchy. Terms associated 721
with numbered terminal nodes are provided in Table S4 . Terminal nodes marked with an * 722
indicate nodes related to a function or process commonly represented in that module network 723 (e.g., several terminal nodes in Module A are related to neurological function and development). 724 offspring surviving for the 9 families sample for RNA-seq (C,D). In A-D, families sampled for 729
RNA-seq are indicated by blue points; note that data were unavailable for some families in 730 panels A-C (i.e., 1 family from panels A and C and 2 families from panel B). 731 positively associated with increasing risk of mortality are largely associated with gene ontology 736 terms related to physiological stress, whereas genes negatively associated with risk are 737 associated with terms related to growth and developmental processes (see Table S6 ). 738 
